Lipoxin
Lipoxin A4 | |
Lipoxin B4 | |
| Names | |
|---|---|
| Preferred IUPAC name
A4: (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid B4: (5S,6E,8Z,10E,12E,14R,15S)-5,14,15-Trihydroxyicosa-6,8,10,12-tetraenoic acid | |
| Other names
LXA4 and LXB4 | |
| Identifiers | |
| |
3D model (JSmol) |
|
| ChEBI | |
| ChemSpider | |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C20H32O5 | |
| Molar mass | 352.46508 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
A lipoxin (LX or Lx), an acronym for lipoxygenase interaction product, is a bioactive autacoid metabolite of arachidonic acid made by various cell types. They are categorized as nonclassic eicosanoids and members of the specialized pro-resolving mediator (SPM) family of polyunsaturated fatty acid (PUFA) metabolites. Like other SPMs, LXs form during an inflammatory response and act to resolve it. The first lipoxins identified were lipoxin A4 (LXA4) and lipoxin B4 (LXB4), followed by their respective epimers, the epi-lipoxins 15-epi-LXA4 and 15-epi-LXB4.